Trump administration's proposal to lower prices might just raise them, critics say

21st June 2017 Uncategorised 0

Biopharma and its investors are breathing a sigh of relief with reports that the Trump Administration is preparing an executive order on pricing that won’t do much harm to its business model. At the same time, critics are blasting the White House for going too easy on drugmakers.

More: Trump administration's proposal to lower prices might just raise them, critics say
Source: fierce